Biosyent Inc opened trading today at $8.50 and closed at $8.40. It traded at a low of $8.40 to a high of $8.50.

Shares $verbed percentage_change percent from the previous day's close of $8.40.

Today across North America, the TSX Composite closed tsx_percentage_change% at 22011.72, the S&P 500 closed sp_500_percentage_change% at 5010.60, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 38239.98 and the Nasdaq Composite closed nasdaq_percentage_change% at 15451.31.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

Trading volume was 2,777 on 12 total trades, while having an average volume of 3,547 over 5 days.

Trading across the entire TSX-V saw 3,894 price advancers against 1,317 declines and 99 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have advanced 8.39% in the last 52 weeks, while this year, they have decreased -8.89%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $97.52 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..